Aclarion to Present at August 20th Virtual Investor Summit Microcap Event
Aclarion to Present at August 20th Virtual Investor Summit Microcap Event
Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy ("MRS"), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies. For more information, please visit . BROOMFIELD, CO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Aclarion, Inc. ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today that it will be presenting at the upcoming Virtual Investor Summit on August 20th, 2024. Investors may request a one-on-one meeting with management by registering here: .
2024年8月15日，科技医疗公司Aclarion（纳斯达克：ACON，ACONW）（以下简称“公司”）宣布，利用生物标志物和专有的增强智能算法帮助医生确定慢性腰痛部位的健康科技公司Aclarion将在2024年8月20日的即将召开的虚拟投资者峰会上发表演讲。投资者可以在这里注册要求与管理层进行一对一会议。 .
Event: Q3 Investor Summit
Date: August 20, 2024
Presentation Time: 4:00 PM ET
Location:
活动：Q3投资者峰会
日期：2024年8月20日
演示时间：美国东部时间下午4点
位置：
About Aclarion, Inc.
关于Aclarion公司
Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy ("MRS"), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies. For more information, please visit .
Aclarion是一家医疗技术公司，利用磁共振光谱(MRS)、专有信号处理技术、生物标志物和增强智能算法来优化临床治疗。公司首先通过Nociscan解决慢性下腰痛市场，它是第一个经过证据支持的SaaS平台，可非侵入性地帮助医生区分腰椎疼痛和非疼痛性椎间盘。通过云连接，Nociscan接收每个腰椎间盘的磁共振光谱(MRS)数据进行评估。在云端，专有信号处理技术提取并量化化学生物标志物，这些标志物已证明与椎间盘疼痛有关。生物标志物数据输入到专有算法中，以指示椎间盘是否可能是疼痛的来源。当与其他诊断工具一起使用时，Nociscan为患者下腰痛的位置提供重要的洞察，使医生了解优化治疗策略的清晰。更多信息，请访问.
Investor Contacts:
Kirin M. Smith
PCG Advisory, Inc.
646.823.8656
ksmith@pcgadvisory.com
投资者联系方式：
Kirin M. Smith
PCG Advisory, Inc.
646.823.8656
ksmith@pcgadvisory.com
Media Contacts:
Jodi Lamberti
SPRIG Consulting
612.812.7477
jodi@sprigconsulting.com
媒体联系人:
Jodi Lamberti
SPRIG Consulting
612.812.7477
jodi@sprigconsulting.com